We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RES:NYSERPC, Inc. Analysis

Data as of 2026-08-23 - not real-time

$6.37

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

At $6.37, RPC, Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. Over a rolling month the price has gained 12.7%. With RSI at 59.2 the momentum picture is neutral, alongside a bullish MACD signal. Recent trading has carved out support near $5.05 and resistance around $6.59.
The shares look overvalued, trading on 57.9 times earnings above a sector average of 21.5. Revenue is growing at 9.5% on a 1.3% profit margin. The 2.51% dividend yield looks stretched against payout coverage.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 41.5%, a beta of 0.32 and a maximum drawdown of 36.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is sell, conviction 4 out of 10.

Top Market Events

Revenue grew 1% sequentially while margins expanded 250 basis points on operational leverage.In the past week, RPC, Inc. reported second-quarter 2026 results showing sales of US$460.87 million and net income of...Oilfield services company RPC NYSE:RES reported Q2 CY2026 results , with sales up 9.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading above the 200-day average of 6.24
  • MACD momentum is positive

Medium Term

1–3 years
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 57.9 versus sector average of 21.5
  • Dividend yield of 2.51% looks stretched against payout coverage

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • P/E of 57.9 versus sector average of 21.5
  • Dividend yield of 2.51% looks stretched against payout coverage
  • Negative free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth9.50%
Profit Margin1.28%
P/E Ratio57.9
ROE2.08%
ROA2.41%
Debt/Equity4.68
P/B Ratio1.3
Op. Cash Flow$183.0M
Free Cash Flow$-5273000
Industry P/E21.5

Technical Analysis

TrendBearish
RSI59.2
Support$5.05
Resistance$6.59
MA 20$5.97
MA 50$6.01
MA 200$6.24
MACDBullish
VolumeDecreasing
Fear & Greed Index94.41

Valuation

Fair Value$11.62
Target Price$6.40
Upside/Downside0.47%
GradeOvervalued
TypeBlend
Dividend Yield2.51%

Risk Assessment

Beta0.32
Volatility41.52%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.